Fate Therapeutics, Inc. (FATE)

NGM – Real Time Price. Currency in USD

2.25

+0.07 (3.21%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

14M

64M

96M

Cost of goods sold

-13M

-19M

-18M

-14M

Gross Profit

-6M

-5M

45M

83M

Operating expenses (excl. COGS)

-140M

-190M

-223M

-391M

Operating Income

-147M

-196M

-178M

-308M

Non-operating income, total

10M

17M

27M

Pretax income

-136M

-186M

-161M

-282M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-136M

-186M

-161M

-282M

Fate Therapeutics, Inc. (FATE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Fate Therapeutics, Inc. (FATE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Fate Therapeutics, Inc. (FATE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Fate Therapeutics, Inc. (FATE)

Income Statement (Annual)

Income Statement (Annual)